{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:20:27Z","timestamp":1793733627585,"version":"4.6.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"am","delay-in-days":331,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of HealthNational Institutes of Health (NIH)","award":["#T32AG019134"],"award-info":[{"award-number":["#T32AG019134"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.drugalcdep.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T01:59:24Z","timestamp":1555984764000},"page":"122-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["Association of current and past opioid use disorders with health-related quality of life and employment among US adults"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4961-3361","authenticated-orcid":false,"given":"Taeho Greg","family":"Rhee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Rosenheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12955-017-0781-y","article-title":"Comparison of health-related quality of life among men with different co-existing severe mental disorders in treatment for substance use","volume":"15","author":"Adan","year":"2017","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jsat.2017.01.019","article-title":"Quality of life as an outcome of opioid use disorder treatment: a systematic review","volume":"76","author":"Bray","year":"2017","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0015","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/01.mlr.0000135827.18610.0d","article-title":"The estimation of a preference-based measure of health from the SF-12","volume":"42","author":"Brazier","year":"2004","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0020","series-title":"Drug Overdose Death Data","author":"Centers for Disease Control and Prevention","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0025","series-title":"Prescription Opioid Data","author":"Centers for Disease Control and Prevention","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0030","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s11136-015-0943-5","article-title":"Quality of life in a community sample of young cocaine and\/or heroin users: the role of mental disorders","volume":"24","author":"Chahua","year":"2015","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0035","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000343098","article-title":"Impact of addiction severity and psychiatric comorbidity on the quality of life of alcohol-, drug- and dual-dependent persons in residential treatment","volume":"19","author":"Colpaert","year":"2013","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0050","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.drugpo.2010.01.010","article-title":"Quality of life among opiate-dependent individuals: a review of the literature","volume":"21","author":"De Maeyer","year":"2010","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0055","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0895-4356(98)00109-7","article-title":"Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International quality of life assessment","volume":"51","author":"Gandek","year":"1998","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0060","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002025.pub5","article-title":"Buprenorphine for managing opioid withdrawal","author":"Gowing","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0065","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on alcohol and related conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jamapsychiatry.2015.2132","article-title":"Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on alcohol and related Conditions-III","volume":"73","author":"Grant","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/0272989X05284108","article-title":"Estimating the association between SF-12 responses and EQ-5D utility values by response mapping","volume":"26","author":"Gray","year":"2006","journal-title":"Med. Decis. Making"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0080","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/ajad.12188","article-title":"Health-related quality of life among prescription opioid-dependent patients: results from a multi-site study","volume":"24","author":"Griffin","year":"2015","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugalcdep.2014.12.011","article-title":"The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample","volume":"148","author":"Hasin","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0090","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0095","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1080\/10826084.2017.1316508","article-title":"DSM-5 tobacco use disorder and sleep disturbance: findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III)","volume":"52","author":"Hayley","year":"2017","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0100","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/ajad.12637","article-title":"Chronic pain and opioid abuse: factors associated with health-related quality of life","volume":"26","author":"Jones","year":"2017","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.drugalcdep.2010.06.009","article-title":"Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence","volume":"112","author":"Karow","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0110","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/10826084.2010.509854","article-title":"Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence","volume":"46","author":"Karow","year":"2011","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0115","first-page":"44","article-title":"The case for considering quality of life in addiction research and clinical practice","volume":"6","author":"Laudet","year":"2011","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09638237.2016.1177771","article-title":"Psychiatric comorbidity and severity of dependence on substance users: how it impacts on their health-related quality of life?","volume":"26","author":"Lozano","year":"2017","journal-title":"J. Ment. Health"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1747-597X-3-2","article-title":"Satisfaction with life and opioid dependence","volume":"3","author":"Luty","year":"2008","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jsat.2018.03.001","article-title":"Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: a systematic review","volume":"89","author":"Maglione","year":"2018","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0135","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0140","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000090426","article-title":"Determinants of health-related quality of life of opiate users at entry to low-threshold methadone programs","volume":"12","author":"Millson","year":"2006","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0145","series-title":"National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III)","author":"National Institute on Alcohol Abuse and Alcoholism","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0150","series-title":"National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III): Source and Accuracy Statement","author":"National Institute on Alcohol Abuse and Alcoholism","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0155","series-title":"Opioid Overdose Crisis","author":"National Institute on Drug Abuse","year":"2019"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0160","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2018.6072","article-title":"QALYs in 2018\u2014 advantages and concerns","volume":"319","author":"Neumann","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0165","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1176\/ajp.2006.163.12.2080","article-title":"Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia","volume":"163","author":"Rosenheck","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0170","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1176\/appi.ps.201500447","article-title":"Cost-effectiveness of long-acting injectable paliperidone palmitate versus haloperidol decanoate in maintenance treatment of schizophrenia","volume":"67","author":"Rosenheck","year":"2016","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0175","series-title":"Bleak New Estimates in Drug Epidemic: A Record 72,000 Overdose Deaths in 2017","author":"Sanger-Katz","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0180","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0185","series-title":"Stata Statistical Software: Release 15","author":"StataCorp LP","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0190","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s11136-017-1538-0","article-title":"Health-related quality of life in patients receiving long-term opioid therapy: a systematic review with meta-analysis","volume":"26","author":"Thornton","year":"2017","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0195","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.psychres.2013.01.016","article-title":"Assessment of the minimum clinically important difference in quality of life in schizophrenia measured by the Quality of Well-Being Scale and disease-specific measures","volume":"209","author":"Thwin","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0200","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1360-0443.2011.03581.x","article-title":"Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders","volume":"107","author":"Tiffany","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0205","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2018.06.001","article-title":"Developing an opioid use disorder treatment cascade: a review of quality measures","volume":"91","author":"Williams","year":"2018","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000113724","article-title":"Quality of life in patients receiving opioid maintenance therapy. A comparative study of slow-release morphine versus methadone treatment","volume":"14","author":"Winklbaur","year":"2008","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2019.03.004_bib0220","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/YCO.0b013e328328d154","article-title":"Quality of life and substance use: concepts and recent tendencies","volume":"22","author":"Zubaran","year":"2009","journal-title":"Curr. Opin. Psychiatry"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619301206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619301206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:57:53Z","timestamp":1759827473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619301206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":44,"alternative-id":["S0376871619301206"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.03.004","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of current and past opioid use disorders with health-related quality of life and employment among US adults","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}